Literature DB >> 11367528

Multiple ligand binding sites on domain seven of human complement factor H.

E Giannakis1, D A Male, R J Ormsby, C Mold, T S Jokiranta, S Ranganathan, D L Gordon.   

Abstract

Foreign particles and damaged host cells can activate the complement system leading to their destruction by the host defense system. Factor H (fH) plays a vital role in restricting complement activation on host cells through interactions with polyanions such as heparin, while allowing activation to proceed on foreign surfaces. Complement activation by damaged host cells is also down regulated by fH, which is localized to injured areas through interactions with C-reactive protein (CRP). A number of pathogens have developed mechanisms by which they can also bind fH and thus exploit its protective properties. One such organism is Group A Streptococcus (GAS) which mediates fH binding via its surface expressed M-protein. fH consists of 20 conserved short consensus repeat (SCR) units and mutagenesis studies indicate that the seventh repeat is responsible for interactions with heparin, CRP and M-protein. We recently performed molecular modelling of fH SCR 7 and identified a cluster of positively charged residues on one face of the domain. By alanine replacement mutagenesis, we demonstrated that these residues are involved in heparin, CRP and M protein binding, which indicates that there is a common site within fH SCR 7 responsible for multiple ligand recognition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11367528     DOI: 10.1016/s1567-5769(00)00040-0

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  13 in total

1.  Genomic location and variation of the gene for CRS, a complement binding protein in the M57 strains of Streptococcus pyogenes.

Authors:  Michael Binks; David McMillan; Kadaba S Sriprakash
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 2.  The role of inflammation in the pathogenesis of age-related macular degeneration.

Authors:  Larry A Donoso; David Kim; Arcilee Frost; Alston Callahan; Gregory Hageman
Journal:  Surv Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 6.048

Review 3.  Recent developments in the treatment of age-related macular degeneration.

Authors:  Frank G Holz; Steffen Schmitz-Valckenberg; Monika Fleckenstein
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

Review 4.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

5.  Studies on the interactions between C-reactive protein and complement proteins.

Authors:  Adrienn Bíró; Zita Rovó; Diana Papp; László Cervenak; Lilian Varga; George Füst; Nicole M Thielens; Gérard J Arlaud; Zoltán Prohászka
Journal:  Immunology       Date:  2007-01-18       Impact factor: 7.397

6.  Analysis of the complement sensitivity of oral treponemes and the potential influence of FH binding, FH cleavage and dentilisin activity on the pathogenesis of periodontal disease.

Authors:  D P Miller; J V McDowell; J K Bell; M P Goetting-Minesky; J C Fenno; R T Marconi
Journal:  Mol Oral Microbiol       Date:  2014-06-03       Impact factor: 3.563

7.  Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid.

Authors:  P T Johnson; K E Betts; M J Radeke; G S Hageman; D H Anderson; L V Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

8.  The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.

Authors:  Thomas G Duthy; Rebecca J Ormsby; Eleni Giannakis; A David Ogunniyi; Uwe H Stroeher; James C Paton; David L Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens.

Authors:  B David Persson; Nikolaus B Schmitz; César Santiago; Georg Zocher; Mykol Larvie; Ulrike Scheu; José M Casasnovas; Thilo Stehle
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

10.  Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?

Authors:  Virginia B Kraus; Joanne M Jordan
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.